Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk

Authors: Gregory S. Thomas, William C. Cromwell, Shariq Ali, Wai Chin, JoAnn Flaim, Michael H. Davidson - Journal of the American College of Cardiology 2013 cited by 246